Apremilast 30 mg twice daily combined with dupilumab for the treatment of recalcitrant moderate-to-severe atopic dermatitis

被引：3
|
作者：
Cunningham, Kaitlynne N. [1 ]
Alsukait, Sarah [1 ]
Cohen, Stephanie R. [1 ]
Learned, Christine [1 ]
Gao, David X. [1 ]
Kachuk, Courtney [1 ]
Dumont, Nicole [1 ]
Zipeto, Alysha [1 ]
Rosmarin, David [2 ]
机构：
[1] Tufts Med Ctr, Dept Dermatol, 800 Washington St, Boston, MA 02111 USA
[2] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN USA
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 06期
关键词：
D O I：
10.1111/jdv.18906
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E765 / E767
页数：3
相关论文
共 50 条
  • [31] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Diana Bernardo
    Thomas Bieber
    Tiago Torres
    American Journal of Clinical Dermatology, 2023, 24 : 753 - 764
  • [32] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [33] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study
    Liu, Bo
    Song, Xiaoting
    Liao, Shuanglu
    Luan, Tingting
    Zhao, Zuotao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 966 - 974
  • [34] Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment
    Linares-Gonzalez, Laura
    Lozano-Lozano, Ignacio
    Gutierrez-Rojas, Luis
    Ruiz-Villaverde, Ricardo
    Lozano-Lozano, Mario
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 607 - 610
  • [35] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
    Irvine, A. D.
    Paller, A.
    Horowitz, J. E.
    Farrell, A.
    Hatsell, S.
    Ehmann, P.
    Rodriguez Marco, A.
    Tian, T.
    Cyr, S. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S110 - S110
  • [36] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [37] Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    Costanzo, Antonio
    Foley, Peter
    Ardeleanu, Marius
    Wu, Jiangming
    Ozturk, Zafer E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [38] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
    Irvine, Alan D.
    Paller, Amy S.
    Horowitz, Julie E.
    Farrell, Annamaria
    Hatsell, Sarah
    Ehmann, Peter
    McDonald, Robert
    Marco, Ainara Rodriguez
    Tian, Tingting
    Cyr, Sonya L.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [39] Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis
    Lans, A.
    Van Luijk, C. M.
    Bakker, D. S.
    Ariens, L. F. M.
    Thijs, J. L.
    Van der Schaft, J.
    De Boer, J. H.
    Knol, E. F.
    De Bruin-Weller, M. S.
    Balak, D. M. W.
    ALLERGY, 2019, 74 : 714 - 714
  • [40] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
    Mareschal, Adrien
    Puzenat, Eve
    Aubin, Francois
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
12345